Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Onconova Therapeutics logo — Onconova is focused on discovering and developing novel prod...

Onconova Therapeutics

Onconova is focused on discovering and developing novel products for patients with cancer.

Founded 1998 United States Newtown, United States 20 employees Post Ipo Equity Total: $177.92M Biopharma, Biotechnology +1

General Information

Company Name Onconova Therapeutics
Founded Year 1998
Location United States Newtown, United States +1
Employees 20
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Onconova Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Onconova Therapeutics

Onconova Therapeutics (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company, founded in 1998 and headquartered in the United States. The company is committed to discovering and developing novel products for patients with cancer, as encapsulated in its slogan: "Onconova is focused on discovering and developing novel products for patients with cancer."

Operating within the Biopharma, Biotechnology, and Health Care industries, Onconova is at the forefront of innovative cancer treatment development, striving to make meaningful contributions to health care and biotechnology.

Their last known investment was a $21.00M Post-IPO Equity investment on 24 September 2021. This financial backing underscores the continued interest and confidence in Onconova's potential to disrupt and innovate within the cancer treatment landscape.

Taxonomy: Onconova Therapeutics, biopharmaceutical company, clinical-stage, cancer research, drug development, oncology treatments, NASDAQ listed, patient-focused, novel cancer products

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 24 Sep 2021
Post-IPO Equity •••••• - 11 Feb 2021
Post-IPO Equity •••••• 2
Investor Investor
07 Jan 2021
Post-IPO Equity •••••• - 08 Jun 2018
Post-IPO Equity •••••• - 01 May 2018

View All 11 Funding Rounds

Onconova Therapeutics Alternatives & Competitors

Onconova Therapeutics vs
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute United States

Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and ad...

Grant
9027 employees
Health Care
Onconova Therapeutics vs
Alethia Biotherapeutics Inc.
Alethia Biotherapeutics Inc. Canada

Immunotherapeutics against disease-specific targets

Debt Financing
12 employees
Biotechnology, Health Care
Onconova Therapeutics vs
Michiana Hematology Oncology (MHO)
Michiana Hematology Oncology (MHO) United States

Bringing world-class cancer care to northern Indiana

53 employees
Health Care, Health and Wellness

FAQ About Onconova Therapeutics

Onconova is focused on discovering and developing novel products for patients with cancer.
Onconova Therapeutics was founded in 1998.
Onconova Therapeutics is headquartered in Newtown, United States.
Onconova Therapeutics operates in the following industries: Biopharma, Biotechnology, Health Care.
Onconova Therapeutics has approximately 20 employees.
Onconova Therapeutics has completed 11 funding rounds, raising a total of $177.92M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Onconova Therapeutics include Dana-Farber Cancer Institute, Alethia Biotherapeutics Inc., Michiana Hematology Oncology (MHO), Rutgers Cancer Institute, University of Colorado Anschutz Cancer Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Onconova Therapeutics and Dana-Farber Cancer Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Onconova Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes